The EuPRAXIA project has been selected to enter the new roadmap of ESFRI (EUROPEAN STRATEGY FORUM ON RESEARCH INFRASTRUCTURES) the network of European research infrastructures.
The acronym EuPRAXIA stands for European Plasma Research Accelerator with Excellence in Applications, where the undisputed protagonist is the innovative accelerator based on plasma technology will be built in the Frascati National Laboratories area. The use of this new technology for particle accelerators will find application in the scientific, medical and industrial fields.
Conventional accelerators use oscillating radio frequency (RF) fields to accelerate charged particles. The acceleration rate in these devices is limited by the dielectric breakdown in the acceleration tube. This limits the amount of acceleration over a given space, requiring very long accelerators to reach high energies.
The alternative idea, compared to conventional particle accelerators, is to use an ionized gas, or plasma, to maintain the high electric fields needed to accelerate the particles. The advantage of plasma accelerators is that their acceleration fields can be much stronger than those of conventional RF accelerators.
The consortium includes European research institutions and industries. For Italy, the INFN, ENEA, CNR, Elettra Sincrotrone Trieste and the universities of Rome Sapienza and Rome Tor Vergata participate.
In particular, Prof. Alessandro Cianchi, Prof.ssa Silvia Morante and Dr. Francesco Stellato actively collaborate in the Physics Department of the University of Rome Tor Vergata.
Link to the ESFRI project: https://www.esfri.eu/latest-esfri-news/new-ris-roadmap-2021?fbclid=IwAR2v14l
Link to the EuPRAXIA project: http://www.eupraxia-project.eu/contact-us.html
